Becton, Dickinson Boosts FY23 Outlook - Update

RTTNews | Pred 823 dňami
Stocktwits
Becton, Dickinson Boosts FY23 Outlook - Update

(RTTNews) - While reporting financial results for the second quarter on Thursday, medical technology company Becton, Dickinson and Co. (BDX) raised its adjusted earnings and revenue outlook for fiscal 2023.

For fiscal 2023, the company now projects adjusted earnings in a range of $12.10 to $12.32 per share on revenues between approximately $19.2 billion to $19.3 billion, with currency-neutral revenue growth of 6.5 to 7.0 percent.

Previously, the company expected adjusted earnings in a range of $12.07 to $12.32 per share on revenues between approximately $19.1 billion to $19.3 billion, with currency-neutral revenue growth of 5.75 to 6.75 percent.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $12.21 per share on revenue growth of 1.9 percent to $19.22 billion for the year. Analysts' estimates typically exclude special items.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Značky: BDX
Stocktwits
read more
BD Recalls ChloraPrep Clear 1 ML Applicators

BD Recalls ChloraPrep Clear 1 ML Applicators

Medical technology company Becton, Dickinson and Co. or BD has recalled one lot of ChloraPrep Clear 1 mL Applicators citing potential fungal contamination, the U.S. Food and Drug Administration said. Under certain environmental conditions, the contamination allows the growth of Aspergillus penicillioides within the packaging.
RTTNews | Pred 166 dňami
Becton, Dickinson Boosts FY24 Ad, EPS Outlook - Update

Becton, Dickinson Boosts FY24 Ad, EPS Outlook - Update

While reporting financial results for the third quarter on Thursday, medical technology company Becton, Dickinson and Co. (BDX) raised its adjusted earnings guidance for fiscal 2024, while trimming annual revenue outlook.
RTTNews | Pred 368 dňami
BD Announces Global Commercial Release Of New BD FACSDiscover S8 Cell Sorters

BD Announces Global Commercial Release Of New BD FACSDiscover S8 Cell Sorters

Medical technology company BD or Becton, Dickinson and Co. (BDX) announced Friday the global commercial release of new cell sorters that will enable more researchers in a broader range of fields, including cell biology, cancer research and immunology, to reveal insights that were previously invisible in traditional flow cytometry experiments.
RTTNews | Pred 486 dňami
BD Gets FDA 510(k) Clearance For Fingertip Blood Collection Device

BD Gets FDA 510(k) Clearance For Fingertip Blood Collection Device

Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Thursday it has received 510(k) clearances from the U.S. Federal Drug Administration (FDA) for a novel blood collection device that obtains blood samples from a fingerstick that produce lab-quality results for some of the most commonly ordered blood tests.
RTTNews | Pred 606 dňami
Becton, Dickinson Boosts FY23 Outlook - Update

Becton, Dickinson Boosts FY23 Outlook - Update

While reporting financial results for the first quarter on Thursday, medical technology company Becton, Dickinson and Co. or BD (BDX) raised its adjusted earnings and revenue outlook for fiscal 2023.
RTTNews | Pred 914 dňami
FTSE 100 Modestly Higher; Lloyds Banking Group Rises Nearly 8%

FTSE 100 Modestly Higher; Lloyds Banking Group Rises Nearly 8%

The UK market is up in positive territory on Monday with stocks from the financial sector contributing significantly to the upmove after the outcome from the UK's motor finance investigation turned out to less severe than feared, with potential compensation estimated at 9 billion pounds, much less than the expected quantum o 30 billion pounds.
RTTNews | Pred 25 minútami
Nástroje
Ekonomický kalendár
Otváracie hodiny trhu
Úrokové sadzby
Kalendár sviatkov
Forexový trh
Forex Volatilita
Korelácia Forexu
Novinky na Forexe
forex analysis
COT Údaje
Likvidita
Forex kalkulačky
Forex Tepelná mapa
Tepelná mapa indikátorov
Komunita
Komunita
Systémy
Najpopulárnejšie systémy
Stratégie
Súťaže
Forexové grafy
Forexový sentiment
Indikátor Outlook
Recenzie
Brokeri
Prop Trading Firms
Služby VPS
Poskytovatelia signálu
Služby programovania EA
Affiliate Programs
Služby brokera PAMM
Služby zľavového programu
Obchodné platformy
Odborní poradcovia
Kryptoburzy
Obchodné kurzy
Brokeri
Forex Spready
Ponuky Forex brokerov
Swapy Forex brokerov
Objem brokera Forexu
Propagačné akcie Forex Brokera Tlačová Správa
Platforma
Miniaplikácie
Funkcie
API
RSS
Stock Portfolio
Affiliate Software
Rozšírené grafy
Podpora
Často kladené otázky
Pomoc
Kontaktuj nás
Nahlásiť chybu!
O
Blog
& copy; 2025 Myfxbook Ltd. Všetky práva vyhradené.
UPOZORNENIE NA VYSOKÉ RIZIKO: Obchodovanie s devízami prináša vysokú úroveň rizika, ktoré nemusí byť vhodné pre všetkých investorov. Páka vytvára ďalšie riziká a straty. Než sa rozhodnete obchodovať s devízami, dôkladne zvážte svoje investičné ciele, úroveň skúseností a toleranciu voči riziku. Môžete prísť o časť alebo všetky svoje počiatočné investície. Neinvestujte peniaze, ktoré si nemôžete dovoliť stratiť. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Všetky údaje a informácie sú poskytované „tak, ako sú“. iba na informačné účely a nie je určené na obchodné účely alebo rady. Výkonnosť v minulosti neznamená výkonnosť v budúcnosti.